208 related articles for article (PubMed ID: 9729284)
1. Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.
Sershen H; Hashim A; Lajtha A
Brain Res; 1998 Aug; 801(1-2):67-71. PubMed ID: 9729284
[TBL] [Abstract][Full Text] [Related]
2. The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice.
Sershen H; Hashim A; Lajtha A
Brain Res Bull; 1995; 36(6):587-91. PubMed ID: 7757494
[TBL] [Abstract][Full Text] [Related]
3. Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum.
Sershen H; Hashim A; Lajtha A
Pharmacol Biochem Behav; 1996 Apr; 53(4):863-9. PubMed ID: 8801590
[TBL] [Abstract][Full Text] [Related]
4. Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
Glick SD; Maisonneuve IM; Pearl SM
Brain Res; 1997 Feb; 749(2):340-3. PubMed ID: 9138735
[TBL] [Abstract][Full Text] [Related]
5. The effect of ibogaine on Sigma- and NMDA-receptor-mediated release of [3H]dopamine.
Sershen H; Hashim A; Lajtha A
Brain Res Bull; 1996; 40(1):63-7. PubMed ID: 8722755
[TBL] [Abstract][Full Text] [Related]
6. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Acri JB; Thompson AC; Shippenberg T
Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785
[TBL] [Abstract][Full Text] [Related]
7. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
Heidbreder CA; Schenk S; Partridge B; Shippenberg TS
Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
[TBL] [Abstract][Full Text] [Related]
8. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
[TBL] [Abstract][Full Text] [Related]
9. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.
Heidbreder CA; Goldberg SR; Shippenberg TS
Brain Res; 1993 Jul; 616(1-2):335-8. PubMed ID: 8395306
[TBL] [Abstract][Full Text] [Related]
10. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
Sershen H; Harsing LG; Hashim A; Lajtha A
Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
[TBL] [Abstract][Full Text] [Related]
11. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
Heidbreder CA; Babovic-Vuksanovic D; Shoaib M; Shippenberg TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):150-63. PubMed ID: 7562544
[TBL] [Abstract][Full Text] [Related]
12. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
Chefer VI; Morón JA; Hope B; Rea W; Shippenberg TS
Neuroscience; 2000; 101(3):619-27. PubMed ID: 11113311
[TBL] [Abstract][Full Text] [Related]
13. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine.
Thompson AC; Zapata A; Justice JB; Vaughan RA; Sharpe LG; Shippenberg TS
J Neurosci; 2000 Dec; 20(24):9333-40. PubMed ID: 11125013
[TBL] [Abstract][Full Text] [Related]
14. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.
Collins SL; Gerdes RM; D'Addario C; Izenwasser S
Behav Pharmacol; 2001 Jul; 12(4):237-45. PubMed ID: 11548109
[TBL] [Abstract][Full Text] [Related]
15. Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome- and matrix-enriched areas of the rat striatum.
Krebs MO; Gauchy C; Desban M; Glowinski J; Kemel ML
J Neurosci; 1994 Apr; 14(4):2435-43. PubMed ID: 7908960
[TBL] [Abstract][Full Text] [Related]
16. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
Collins SL; D'Addario C; Izenwasser S
Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
[TBL] [Abstract][Full Text] [Related]
17. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
Vanderschuren LJ; Schoffelmeer AN; Wardeh G; De Vries TJ
Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
[TBL] [Abstract][Full Text] [Related]
18. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
19. Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2004 Apr; 172(4):422-9. PubMed ID: 14712335
[TBL] [Abstract][Full Text] [Related]
20. Ibogaine antagonizes cocaine-induced locomotor stimulation in mice.
Sershen H; Hashim A; Harsing L; Lajtha A
Life Sci; 1992; 50(15):1079-86. PubMed ID: 1556903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
